GEn1E is a clinical-stage company focused on developing 1st-in-class precision therapies for inflammatory and rare diseases, utilizing a unique AI platform to accelerate drug discovery and clinical trials
GEn1E is a clinical-stage company focused on developing 1st-in-class precision therapies for inflammatory and rare diseases, utilizing a unique AI platform to accelerate drug discovery and clinical trials.